Unexplained persistent nausea and vomiting: identifying cannabinoid hyperemesis syndrome in a clinical case

Authors

  • Carolina Pinto-Gouveia Médica Interna de Psiquiatria. Centro Hospitalar e Universitário de Coimbra (CHUC). Coimbra, Portugal.
  • Joana Marques Pinto Médica Interna de Psiquiatria. Centro Hospitalar e Universitário de Coimbra (CHUC). Coimbra, Portugal.
  • Susana Renca Médica Psiquiatra. Centro Hospitalar e Universitário de Coimbra (CHUC). Coimbra, Portugal.

DOI:

https://doi.org/10.32385/rpmgf.v40i2.13685

Keywords:

Marijuana abuse, Cannabinoids, Syndrome, Vomiting, Nausea, Compulsive behavior, Baths, Case report

Abstract

Introduction: Cannabis is the illicit drug with the highest rate of abuse over a lifetime in Portugal. Although its medicinal use due to its antiemetic properties, a new and paradoxical clinical entity has been recognized – cannabinoid hyperemesis syndrome (CHS) – characterized by chronic cannabinoid consumption, cyclic episodes of difficult-to-treat nausea and vomiting, and compulsive hot showers for symptom relief.

Case report: 36-year-old woman, with a history of multiple visits to primary health care center complaining about nausea and cyclic vomiting, still under investigation. She presented to the emergency department (ER) with complaints of epigastric pain, nausea, and vomiting for three days. Laboratory and imaging studies were carried out and did not show any significant alterations. Antiemetic medication and pantoprazole were given, with little improvement in the complaints. During her stay in the ER, she was found several times taking hot showers, repeatedly asking to do so, stating that it was the only measure that alleviated her complaints. In addition, a history of chronic cannabinoid use was found and consequently, the diagnosis of CHS was hypothesized.

Comment: There is a common delay in the diagnosis of this syndrome, which leads to multiple hospitalizations, complementary diagnostic tests, and therapeutics. Thus, we aim to raise awareness of CHS among the medical community as a differential diagnosis of difficult-to-treat recurrent vomiting in individuals with a history of cannabinoid use. This case report aims to promote knowledge about CHS, enabling a timely identification and appropriate therapeutic approach to this diagnosis.

Downloads

Download data is not yet available.

References

World Health Organization. Cannabis [homepage]. Geneva: WHO; 2023. Available from: https://www.who.int/substance_abuse/facts/cannabis/en/

Karila L, Roux P, Rolland B, Benyamina A, Reynaud M, Aubin HJ, et al. Acute and long-term effects of cannabis use: a review. Curr Pharm Des. 2014;20(25):4112-8.

Allen JH, de Moore GM, Heddle R, Twartz JC. Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse. Gut. 2004;53(11):1566-70.

Whiting PF, Wolff RF, Deshpande S, Di Nisio M, Duffy S, Hernandez AV, et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA. 2015;313(24):2456-73.

Fleming JE, Lockwood S. Cannabinoid hyperemesis syndrome. Fed Pract. 2017;34(10):33-6.

Sorensen CJ, DeSanto K, Borgelt L, Phillips KT, Monte AA. Cannabinoid hyperemesis syndrome: diagnosis, pathophysiology, and treatment: a systematic review. J Med Toxicol. 2017;13(1):71-87.

Serviço de Intervenção nos Comportamentos Aditivos e nas Dependências. Caracterização e evolução da situação – Tendências por drogas: cannabis [Internet]. Lisboa: SICAD; 2022 [cited 2022 Oct 11]. Available from: http://www.sicad.pt/BK/EstatisticaInvestigacao/Documents/2020/Tendências_por_Drogas_Cannabis.pdf

Simonetto DA, Oxentenko AS, Herman ML, Szostek JH. Cannabinoid hyperemesis: a case series of 98 patients. Mayo Clin Proc. 2012;87(2):114-9.

Blumentrath CG, Dohrmann B, Ewald N. Cannabinoid hyperemesis and the cyclic vomiting syndrome in adults: recognition, diagnosis, acute and long-term treatment. Ger Med Sci. 2017;15:Doc06.

Richards JR, Gordon BK, Danielson AR, Moulin AK. Pharmacologic treatment of cannabinoid hyperemesis syndrome: a systematic review. Pharmacotherapy. 2017;37(6):725-34.

Richards JR. Cannabinoid hyperemesis syndrome: pathophysiology and treatment in the emergency department. J Emerg Med. 2018;54(3):354-63.

Chocron Y, Zuber JP, Vaucher J. Cannabinoid hyperemesis syndrome. BMJ. 2019;366:l4336.

Ferreira TF, Oliveira C, Dehanov S, Figueiredo I, Dias M, Morins M. Cannabinoid hyperemesis syndrome: a practical review for clinicians. Gaz Med. 2020;3(7):254-62.

Richards JR, Lapoint JM, Burillo-Putze G. Cannabinoid hyperemesis syndrome: potential mechanisms for the benefit of capsaicin and hot water hydrotherapy in treatment. Clin Toxicol (Phila). 2018;56(1):15-24.

Galli JA, Sawaya RA, Friedenberg FK. Cannabinoid hyperemesis syndrome. Curr Drug Abuse Rev. 2011;4(4):241-9.

Sun S, Zimmermann AE. Cannabinoid hyperemesis syndrome. Hosp Pharm. 2013;48(8):650-5.

Published

2024-04-30

How to Cite

Unexplained persistent nausea and vomiting: identifying cannabinoid hyperemesis syndrome in a clinical case. (2024). Portuguese Journal of Family Medicine and General Practice, 40(2), 180-3. https://doi.org/10.32385/rpmgf.v40i2.13685